blog

Celebrating #NextGenContraception on World Contraception Day
The CTI Exchange joins global partners in celebrating World Contraception Day. To celebrate, we are pleased to share highlights from our recent #NextGenContraception campaign. Read full article
blog

FDA approvals for Annovera and Natural Cycles app
On August 10, 2018, the U.S. Food and Drug Administration made two major announcements related to contraception. The FDA permitted marketing of Natural Cycles and it approved AnnoveraTM. Read full article
blog

Newly Published: Can WIN 18,446 function as a nonhormonal female contraceptive? 
Vitamin A deficient women produce less retinoic acid, and this deficiency reduces their fertility. Meanwhile, the compound WIN 18,446 inhibits retinoic acid production. WIN 18,446 has a... Read full article
blog

A Summer in Contraceptive Development
This summer, we got to work in CTI as undergraduate interns. We knew we were going to be working in contraceptive research and development (R&D), but there were far fewer lab coats and chemi... Read full article
blog

New Summer Twitter Campaign: #NextGenContraception
The CTI Exchange’s summer social media campaign aims to highlight the importance of new contraceptive research and development to meet the needs and preferences of women and men globally. ... Read full article
blog

Report on the International Family Planning Landscape
The Center for Global Development (CGD) and Kaiser Family Foundation (KFF) held an international family planning leadership retreat to discuss the current landscape of the field. Read full article
blog

Newly Published Results of a Phase I/II Trial for LNG-only Patches
A recently published article reports on a phase I/II pharmacokinetic and pharmacodynamic clinical trial of two levonorgestrel (LNG)-only contraceptive patches. Read full article
blog

Published Review on Responses to Contraceptive-Induced Menstrual Changes
A recently published review in Reproductive Health summarizes research on women’s responses to contraceptive-induced menstrual bleeding changes (CIMBCs). Read full article
blog

Vaginal Ring Dose-Finding Results Published
Results from a dose-finding study on a novel vaginal ring utilizing 17β-estradiol rather than ethinyl estradiol were published in the May issue of Contraception. Read full article
event

Upcoming Webinar Series: “Mind the Gap”
The Reproductive Health Supplies Coalition is hosting a webinar series, titled “Mind the Gap”, on their latest Global Contraceptive Commodity Gap Analysis (CGA 2018). View Event
blog

NIH Announces Funding for Novel Contraceptive Methods
The National Institutes of Health has released a new funding solicitation to support the development of novel nonsteroidal contraceptive methods. Read full article
blog

Contraceptive Technology Innovation: A Wise Investment
As long as women and men find current family planning methods unacceptable, unaffordable, or inaccessible, there will be a need to invest in contraceptive technology innovation. Read full article